# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Charles Darwin (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI003-SYN
- Date: 2026-03-03
- Fictional facility: St. Posthumous Health Center
- Fictional author: Bernard Ashworth, MD
- Calendar frame: modern shifted

## What we are working on

- For more than a year he has had episodes of nausea and repeated vomiting every one to three weeks, each lasting about 12 to 36 hours, that stop his work; this winter they came almost every week **S**
- Each episode begins with nausea, sweating, trembling hands, a racing heart, and a swimming head; between episodes he has troublesome wind and tires easily, but does not vomit **S**
- He worries about being taken ill in company and has begun to avoid gatherings and travel **S**

## Your goals

- Complete the work-up between episodes (blood and urine tests, ECG, CT enterography, and upper endoscopy) before the six-week visit. Target: 2026-04-14. Recorded outcome: All tests normal; Rome IV criteria met; provisional diagnosis of cyclic vomiting syndrome at the consultation. **S**
- At least half as many episodes after three months at the target dose of prophylaxis. Target: 2026-09-08. Recorded outcome: About two episodes a month before treatment; one brief episode, aborted at the prodrome, in the three months before the six-month review. **S**
- Carry the abortive medicines and the emergency department letter, and use them at the prodrome. Target: 2026-06-09. Recorded outcome: The one episode since starting treatment was treated at the prodrome and settled in about ten hours without an emergency visit; letter carried. **S**
- QTc below 450 ms at the target amitriptyline dose. Target: 2026-06-09. Recorded outcome: QTc 436 ms on 75 mg. **S**
- Practice relaxation breathing most days and lower the GAD-7 score by the six-month review. Target: 2026-09-08. Recorded outcome: Daily breathing practice; GAD-7 from 8 to 5. **S**

## What we agreed to do

- Work-up between episodes: blood count, metabolic and liver panels, lipase, urinalysis, TSH, morning cortisol, celiac serology, a baseline ECG, CT enterography, and upper endoscopy. Guideline: Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) **S**
- Gastroenterology consultation to confirm the diagnosis and advise on prophylaxis, abortive treatment, and an emergency plan. Guideline: Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) **S**
- Symptom diary: date, prodrome, length and severity of each episode, triggers, medicines taken, and emergency visits. Guideline: Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) **S**
- Amitriptyline prophylaxis at bedtime: 25 mg, raised by 25 mg every two weeks to 75 mg (about 1 mg/kg), with an ECG at baseline, at about 50 mg, and at the target dose; judge the response after three months at target and continue for at least a year if it helps. Guideline: Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) **S**
- Abortive plan at the first sign of the prodrome: sumatriptan 20 mg nasal spray with ondansetron 8 mg dissolving tablet, a dark quiet room, and small sips of fluid; an individualized emergency department letter for episodes that do not settle. Guideline: Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) **S**
- Trigger management: regular meals and sleep, planning around travel and social events, early treatment of infections, and continued avoidance of cannabis. Guideline: Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) **S**
- Anxiety and mood: GAD-7 and PHQ-9 at the first visit and every three months; relaxation breathing, with cognitive behavioral therapy offered if symptoms persist. Guideline: Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019); Anxiety Disorders in Adults: Screening (2023) **S**

## Follow-up

- 2026-03-03: Evaluation of recurrent vomiting episodes: history, symptom diary, Rome IV criteria, red flags, cannabis and substance history, anxiety and mood screens, laboratory tests, ECG, and orders for small-bowel imaging and upper endoscopy **S**
- 2026-04-14: Six-week follow-up: results, gastroenterology consultation, provisional diagnosis, prophylaxis, and abortive plan **S**
- 2026-06-09: Three-month review: amitriptyline at target dose, ECG, episode diary, and anxiety screen **S**
- 2026-07-21: Preventive health visit **S**
- 2026-09-08: Six-month review of response to prophylaxis **S**

This teaching document does not replace care from a qualified clinician.
